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Methods

Severe Acute Respiratory Syndrome Coronavirus-1 (SARS CoV-1)
and Middle East Respiratory Syndrome (MERS), two illnesses
caused by a coronavirus, have been shown to affect maternal and
neonatal morbidity and mortality.1-6 Coronavirus disease 2019
(COVID-19), also known as Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS CoV-2), has been shown to affect vasculature
and cause placental changes such as microcalcifications, increased
fibrin, and thrombi formation.7, 8-11

We will conduct a retrospective chart review of all women who tested
positive for COVID-19 during pregnancy or at the time of delivery
and their infants from March 1, 2020 – April 1, 2021 at a single
academic institution. In addition, we will also conduct a retrospective
chart review of 100 healthy women during the same time to serve as
the control group in order to compare the outcomes of those with
and those without COVID-19 infection during pregnancy.

Furthermore, the placenta is a vital organ of pregnancy that plays a
key role in both maternal and fetal health. It serves many functions
to the developing fetus including endocrine regulation, waste
removal, providing a barrier against infection, and transport of
nutrients.12-16

The inclusion criteria are defined as

Significant remodeling of the placenta occurs at the end of the first
trimester and beginning of the second trimester. Therefore, insults
during this crucial time for development can affect the placenta’s
overall size and functional capacity. 12,15,17
These changes have been hypothesized to contribute to intrauterine
fetal growth restriction (IUGR). Importantly, initial studies have
demonstrated that the majority of mothers infected with Covid-19
during pregnancy and neonates born to Covid-19 positive mothers
experience good outcomes. 2,3,7,18

Objectives
1. To obtain the birth characteristics including gestational age and
birth weight from infants that were born to mothers with COVID-19
infection during pregnancy.
2. We will complete a sub-analysis to look at the impact of infection
during the first, second, and third trimester of pregnancy on the
birth characteristics of the infants.
3. We will complete a chart review of 100 healthy women as the
control group to compare the outcomes of those with COVID-19
infection during pregnancy.

Selection of Patients:
1) Any women with a positive pregnancy test and positive
COVID-19 screening test between 3/1/20 – 4/1/21
2) Women must have delivered the infant at UNMH
3) Women with a positive pregnancy test and no other known
complications will be included as the control group
Regarding exclusion criteria, as this is a retrospective chart review, if
the inclusion criteria are met, the mother infant dyad will be included.
No specific ages will be excluded. If a woman has a positive
pregnancy test and positive COVID-19 test, they will be included.

Anticipated Results
Our data collection and statistical analysis are currently ongoing.
However, given the possible effects of Covid-19 infections on the
placenta and, therefore, the developing fetus, we anticipate that
antenatally acquired maternal Covid-19 infections will negatively
impact fetal growth. We anticipate that neonates born to mothers
who acquired Covid-19 infection during pregnancy will be smaller at
birth compared to neonates born to mothers that were not exposed
to Covid-19 during pregnancy.
Additionally, given the crucial period for placental remodeling, we
anticipate that timing of antenatal infections will have varying effects
on neonatal weight at birth.
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Discussion
As Covid-19 is a novel coronavirus, more research is needed to
characterize the rate of antenatal complications due to Covid-19
and whether timing of infection has variable effects on fetal growth.
The CDC reported data between March 2020 – January 2021 from
participating jurisdictions on 9,383 pregnant women with COVID-19
infections. Of these women, data on timing of infection was only
available for 6,313 women of which 71% of infections occurred in
the third trimester.19 Therefore, we would expect that the placenta
would not be undergoing significant vascular remodeling during
what appears to be the most common timing of infection.
There are limited studies regarding this topic, but one study
evaluating 55 cases of Covid-19 infection during pregnancy
reported IUGR affecting approximately 10% of COVID-19
pregnancies.18 Other studies evaluating the pooled rate of
complications for all coronavirus infections including SARS CoV-1,
MERS, and Sars CoV-2 reported a rate of IUGR ranging from 2.8%
to 40%, depending on the study. Given the limited literature and the
wide variability, we hope our study will help to shed more light on
COVID-19 and its effects on mothers and neonates.1,2,6
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